You searched for "patients"
Ten-year experience with intracameral chemotherapy for aqueous seeding in retinoblastoma: long-term efficacy, safety and toxicity
This is a retrospective review of all consecutive patients with primary (n=4) or secondary non-iatrogenic (n=16) aqueous seeding (AS) treated by intracameral chemotherapy (ICC) in Lausanne between 2011 and 2020 with a minimum follow-up of one year. Aqueous seeding control...A game changer in meibomian gland treatment
Introducing the new Meibomian Gland Dredger by Gaush Meditech Ltd. Meibomian gland dredging is important in the treatment of dry eye and has a great influence on treatment outcomes. Many types of dye eye treatment combined with meibomian gland dredging...Graham Popham joins Glaukos as Senior Director, Market Access EMEAI
Glaukos are delighted to announce the appointment of Graham Popham as Senior Director, Market Access EMEAI. Graham comments: "’I'm excited to join Glaukos at such a pivotal time in the evolution of ophthalmic care and growth of the organisation. Throughout...Moorfields Education: New to Ophthalmology programme
Moorfields Education: New to Ophthalmology programmeSustainability in cataract surgery: Everyday practice at Kabgayi
Reading the Royal College of Ophthalmologists’ (RCOphth) ‘Sustainable Cataract Surgery’ guidance (September 2025) was a pleasant surprise [1]. Many of its recommendations mirror what we have been doing at Kabgayi Eye Unit for years, not because of formal policy, but...Martial arts mum fights for inclusive employment
A visually impaired mum in West Lothian is calling for more accessible and inclusive employment for people with sight loss. Amanda Whitfield (35) recently won medals alongside her five-year-old daughter in mixed martial arts, after taking part in local family...Mucormycosis: In conversation with Dr Deepak Haldipur and Dr Aditya Moorthy
COVID-19 has ravaged the world in the past 18 months. The second wave in many countries was deadlier than the first. Mucormycosis, infamously labelled ‘the black fungus’ has affected some countries, such as India, in epidemic proportions within this COVID...The first on-call
You’ve made into ophthalmic specialist training and before you know it, it’s your first on-call shift. You are expected to provide the specialist on-call service out of hours and there is a new wave of responsibility, with, let’s be honest,...CHEC achieves Investors in People status
CHEC, one of the largest providers of community-based ophthalmology services in the UK, has achieved Investors in People status, with its company values and culture pinpointed as being fundamental to the company’s success.
VIBIM Study: One-year results of treatment of DME with aflibercept using TnE
The VIBIM study (the treat-and-extend regimen (TER) using intravitreal aflibercept in diabetic macular edema (DME) study) was designed to evaluate the efficacy of the TER using aflibercept in the management of DME for a period of two years. The authors...
